Denali Therapeutics Stock Math Operators Price Series Multiplication

DNLI Stock  USD 21.67  0.83  3.98%   
Denali Therapeutics math operators tool provides the execution environment for running the Price Series Multiplication operator and other technical functions against Denali Therapeutics. Denali Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of math operators indicators. As with most other technical indicators, the Price Series Multiplication operator function is designed to identify and follow existing trends and Viridian Therapeutics. Math Operators module provides interface to determine different price movement patterns of similar pairs of equity instruments such as Viridian Therapeutics and Denali Therapeutics.

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Denali Therapeutics Price Series Multiplication is a cross multiplication of Denali Therapeutics price series and its benchmark/peer.

Denali Therapeutics Technical Analysis Modules

Most technical analysis of Denali Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Denali from various momentum indicators to cycle indicators. When you analyze Denali charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Denali Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Denali Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Denali Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Denali Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Denali Therapeutics's daily price indicators and compare them against related drivers, such as math operators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Denali Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Denali Therapeutics, we also check how macroeconomic factors affect Denali Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2025 2026 (projected)
Interest Debt Per Share0.380.270.33
Revenue Per Share2.412.171.12
Hype
Prediction
LowEstimatedHigh
16.8920.8824.87
Details
Intrinsic
Valuation
LowRealHigh
18.7626.1030.09
Details
Naive
Forecast
LowNextHigh
17.0321.0225.01
Details
19 Analysts
Consensus
LowTargetHigh
29.9032.8636.47
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Sign In To Macroaxis Now

   

Sign In To Macroaxis

Sign in to explore Macroaxis' wealth optimization platform and fintech modules
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested over 40 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 30 shares
Driverless Cars Idea
Driverless Cars
Invested over 30 shares
Investor Favorites Idea
Investor Favorites
Invested over 50 shares
Advertising Idea
Advertising
Invested few shares
Climate Change Idea
Climate Change
Invested over 90 shares
Technology Idea
Technology
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Impulse Idea
Impulse
Invested few shares
When determining whether Denali Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Denali Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Denali Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Denali Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Denali Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is there potential for Biotechnology market expansion? Will Denali introduce new products? Factors like these will boost the valuation of Denali Therapeutics. Projected growth potential of Denali fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.92)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.27)
Return On Equity
(0.44)
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Denali Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Denali Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Denali Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.